New evidence shows physical activity, especially walking, can significantly improve survival in breast cancer patients, even those genetically prone to obesity, highlighting fitness, early detection, ...
The benefit of PARP inhibitors varied significantly based on the tumor's molecular profile, particularly its homologous recombination repair capability. While patients with deficiencies in this ...
A new Brazilian study has revealed the key role of the protein periostin and stellate pancreatic cells in allowing pancreatic ...
SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...
New research presented at ASCO GI positions both agents as potent therapeutic options, with potential to redefine standard ...
An Alabama Senate committee unanimously approved a bill Wednesday morning that would require health insurance companies to ...
ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc.
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...
Most health advice circles back to the same message: protect your heart. From blood pressure and cholesterol to diet and ...
Zanidatamab + chemotherapy, with or without tislelizumab, may increase survival in metastatic or locally advanced gastroesophageal adenocarcinoma ...
A new report from the American Cancer Association predicts lung cancer will cause more deaths than any other in 2026.